OTCM
ETST
Market cap44mUSD
Jul 09, Last price
0.16USD
1D
6.90%
1Q
19.41%
IPO
-78.47%
Name
Earth Science Tech Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Earth Science Tech, Inc. (EST) is a biotechnology firm dedicated to the worldwide development and distribution of nutraceuticals, bioceuticals, and dietary supplements. These offerings aim to support general health, overall well-being, nutrition, and address specific needs within the cosmetic and alternative medicine sectors. The company's nutritional and dietary supplements are specifically formulated to help manage a wide range of conditions, including chronic and joint discomfort, inflammation, seizures, hypertension, cognitive decline, mood imbalances, weight management, nausea, and the physiological effects of aging, while also promoting overall vitality. EST's diverse product portfolio features items such as various hemp oils, essential vitamins and minerals, a broad selection of herbal and botanical extracts, personal care solutions, homeopathic remedies, and functional food products. These are offered in numerous forms, including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herb preparations. Distribution channels include the company's own retail store, medical clinics, pharmacies, and online platforms. In addition to its wellness products, Earth Science Tech also provides medical equipment and devices. Founded in 2010, the company initially operated under the name Ultimate Novelty Sports, Inc. before officially rebranding to Earth Science Tech, Inc. in March 2014. Its corporate headquarters are located in Doral, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||